SCHEMBL31695320

SCHEMBL31695320

N#Cc1c(-c2cccnc2)cc(-c2ccc(F)cc2)[nH]c1=N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.55
▸ GAA P10253 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ HPGD P15428 1/20 0.55
▸ SQOR Q9Y6N5 1/20 0.53
▸ MET P08581 1/20 0.52
▸ KDR P35968 1/20 0.52
▸ GCGR P47871 3/20 0.46
▸ MAPK14 Q16539 3/20 0.46
▸ GLA P06280 2/20 0.44
▸ NPY5R Q15761 1/20 0.43
▸ CYP19A1 P11511 1/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ IKBKB O14920 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23841138 0.85 ATM (0.57) KDM4EGAAALDH1A1HPGDSQOR
SCHEMBL31695290 0.84 MET (0.48) KDM4EGAAALDH1A1HPGDSQOR
SCHEMBL31695313 0.79 IL4 (0.54) KDM4EGAAALDH1A1GCGRMAPK14
SCHEMBL29335418 0.79 IL4 (0.54) KDM4EGAAALDH1A1GCGRMAPK14
SCHEMBL31695294 0.78 KDR (0.50) KDM4EGAAALDH1A1HPGDSQOR
SCHEMBL23920029 0.78 PIM1 (0.47) KDM4EGAAALDH1A1METKDR
SCHEMBL31695360 0.76 IL4 (0.43) KDM4EGAAALDH1A1GCGRMAPK14
SCHEMBL31695334 0.76 IL4 (0.43) KDM4EGAAALDH1A1METKDR
SCHEMBL23841123 0.74 MAPK14 (0.47) KDM4EGAAALDH1A1HPGDSQOR
SCHEMBL29331948 0.74 SQOR (0.53) KDM4EGAAALDH1A1HPGDSQOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 KDM4E 551/4885GAA 3635/4885ALDH1A1 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback